The Procter & Gamble Company Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 50 rows in 2023. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2023-11-30: Reporting owner Keith R. Alexandra; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2023-11-30: Reporting owner Keith R. Alexandra; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2023-11-14: Reporting owner Keith R. Alexandra; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2023-11-14: Reporting owner Keith R. Alexandra; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-11-30 | Keith R. Alexandra Officer (CEO - Beauty) | 4 | Stock Option (Right to Buy) Derivative · Indirect · (m) | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,408 0 owned after | $78.52 exercise price | $153.52 | 2023-12-04 |
| 2023-11-30 | Keith R. Alexandra Officer (CEO - Beauty) | 4 | Stock Option (Right to Buy) Derivative · Indirect · (m) | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,167 0 owned after | $98.55 exercise price | $153.52 | 2023-12-04 |
| 2023-11-14 | Keith R. Alexandra Officer (CEO - Beauty) | 4 | Stock Option (Right to Buy) Derivative · Indirect · (m) | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,122 1,408 owned after | $78.52 exercise price | $152.12 | 2023-11-16 |
| 2023-11-14 | Keith R. Alexandra Officer (CEO - Beauty) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −19,661 0 owned after | $98.55 exercise price | $152.12 | 2023-11-16 |
| 2023-11-06 | Schulten Andre Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −18,095 0 owned after | $85.13 exercise price | $150.94 | 2023-11-07 |
| 2023-11-06 | Schulten Andre Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −22,203 0 owned after | $80.29 exercise price | $150.94 | 2023-11-07 |
| 2023-10-27 | Aguilar Moses Victor Javier Officer (Chf Rsch, Dev & Innov Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,946 0 owned after | $78.66 exercise price | $147.16 | 2023-10-30 |
| 2023-10-02 | Purushothaman Balaji Officer (Chief Human Resources Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +27,215 27,215 owned after | $145.19 exercise price | $145.19 | 2023-10-04 |
| 2023-10-02 | Aguilar Moses Victor Javier Officer (Chf Rsch, Dev & Innov Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +38,878 38,878 owned after | $145.19 exercise price | $145.19 | 2023-10-04 |
| 2023-10-02 | Coombe Gary A Officer (CEO - Grooming) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +54,590 54,590 owned after | $145.19 exercise price | $145.19 | 2023-10-04 |
| 2023-10-02 | Keith R. Alexandra Officer (CEO - Beauty) | 4 | Stock Option (Right to Buy) Derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,168 12,168 owned after | $145.19 exercise price | $145.19 | 2023-10-04 |
| 2023-10-02 | Keith R. Alexandra Officer (CEO - Beauty) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +55,131 55,131 owned after | $145.19 exercise price | $145.19 | 2023-10-04 |
| 2023-10-02 | Schulten Andre Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +41,107 41,107 owned after | $145.19 exercise price | $145.19 | 2023-10-04 |
| 2023-10-02 | Janzaruk Matthew W. Officer (SVP - Chief Accounting Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,770 8,770 owned after | $145.19 | $145.19 | 2023-10-04 |
| 2023-10-02 | Moeller Jon R Director, Officer (Chairman, President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +163,695 163,695 owned after | $145.19 exercise price | $145.19 | 2023-10-04 |
| 2023-10-02 | Jejurikar Shailesh Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +92,079 92,079 owned after | $145.19 exercise price | $145.19 | 2023-10-04 |
| 2023-10-02 | Whaley Susan Street Officer (Chief Legal Officer & Secy) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,952 20,952 owned after | $145.19 exercise price | $145.19 | 2023-10-04 |
| 2023-10-02 | Pritchard Marc S. Officer (Chief Brand Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +44,666 44,666 owned after | $145.19 exercise price | $145.19 | 2023-10-04 |
| 2023-10-02 | Davis Jennifer L. Officer (CEO - Health Care) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +52,251 52,251 owned after | $145.19 exercise price | $145.19 | 2023-10-04 |
| 2023-10-02 | Francisco Ma. Fatima Officer (CEO - Baby, Fem & Family Care) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +59,252 59,252 owned after | $145.19 exercise price | $145.19 | 2023-10-04 |
| 2023-10-02 | Raman Sundar G. Officer (CEO-Fabric & Home Care) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +52,792 52,792 owned after | $145.19 exercise price | $145.19 | 2023-10-04 |
| 2023-09-15 | Aguilar Moses Victor Javier Officer (Chf Rsch, Dev & Innov Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +13,240 13,240 owned after | $153.47 | $153.47 | 2023-09-19 |
| 2023-09-15 | Keith R. Alexandra Officer (CEO - Beauty) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +27,747 27,747 owned after | $153.47 | $153.47 | 2023-09-19 |
| 2023-09-15 | Keith R. Alexandra Officer (CEO - Beauty) | 4 | Stock Option (Right to Buy) Derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,571 8,571 owned after | $153.47 | $153.47 | 2023-09-19 |
| 2023-09-15 | Purushothaman Balaji Officer (Chief Human Resources Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,938 8,938 owned after | $153.47 | $153.47 | 2023-09-19 |
| 2023-08-09 | Francisco Ma. Fatima Officer (CEO - Baby, Fem & Family Care) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 64,289 owned after | $91.07 exercise price | $156.89 | 2023-08-10 |
| 2023-08-03 | Purushothaman Balaji Officer (Chief Human Resources Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,629 0 owned after | $85.13 exercise price | $157.00 | 2023-08-07 |
| 2023-08-01 | Janzaruk Matthew W. Officer (SVP - Chief Accounting Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,018 0 owned after | $80.29 exercise price | $156.25 | 2023-08-02 |
| 2023-08-01 | Janzaruk Matthew W. Officer (SVP - Chief Accounting Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −13,487 0 owned after | $91.07 exercise price | $156.25 | 2023-08-02 |
| 2023-08-01 | Janzaruk Matthew W. Officer (SVP - Chief Accounting Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,517 0 owned after | $78.52 exercise price | $156.25 | 2023-08-02 |
| 2023-05-01 | Jejurikar Shailesh Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −31,000 31,275 owned after | $80.29 exercise price | $156.57 | 2023-05-02 |
| 2023-04-26 | Whaley Susan Street Officer (Chief Legal Officer & Secy) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,631 2,632 owned after | $113.23 exercise price | $154.58 | 2023-04-28 |
| 2023-04-26 | Janzaruk Matthew W. Officer (SVP - Chief Accounting Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,153 0 owned after | $78.66 exercise price | $154.58 | 2023-04-27 |
| 2023-04-26 | Janzaruk Matthew W. Officer (SVP - Chief Accounting Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,269 0 owned after | $85.13 exercise price | $154.58 | 2023-04-27 |
| 2023-04-25 | Coombe Gary A Officer (CEO - Grooming) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,337 0 owned after | $85.13 exercise price | $156.39 | 2023-04-26 |
| 2023-04-24 | Davis Jennifer L. Officer (CEO - Health Care) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −23,943 0 owned after | $78.52 exercise price | $156.35 | 2023-04-25 |
| 2023-04-24 | Schulten Andre Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,220 0 owned after | $78.66 exercise price | $156.35 | 2023-04-25 |
| 2023-04-24 | Purushothaman Balaji Officer (Chief Human Resources Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,300 12,629 owned after | $85.13 exercise price | $156.35 | 2023-04-25 |
| 2023-01-04 holding as of filing | Purushothaman Balaji Officer (Chief Human Resources Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $85.13 exercise price | 2023-01-04 | ||
| 2023-01-04 holding as of filing | Purushothaman Balaji Officer (Chief Human Resources Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $80.29 exercise price | 2023-01-04 | ||
| 2023-01-04 holding as of filing | Purushothaman Balaji Officer (Chief Human Resources Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $88.06 exercise price | 2023-01-04 | ||
| 2023-01-04 holding as of filing | Purushothaman Balaji Officer (Chief Human Resources Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $91.07 exercise price | 2023-01-04 | ||
| 2023-01-04 holding as of filing | Purushothaman Balaji Officer (Chief Human Resources Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $78.52 exercise price | 2023-01-04 | ||
| 2023-01-04 holding as of filing | Purushothaman Balaji Officer (Chief Human Resources Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $98.55 exercise price | 2023-01-04 | ||
| 2023-01-04 holding as of filing | Purushothaman Balaji Officer (Chief Human Resources Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $113.23 exercise price | 2023-01-04 | ||
| 2023-01-04 holding as of filing | Purushothaman Balaji Officer (Chief Human Resources Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $139.24 exercise price | 2023-01-04 | ||
| 2023-01-04 holding as of filing | Purushothaman Balaji Officer (Chief Human Resources Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $139.58 exercise price | 2023-01-04 | ||
| 2023-01-04 holding as of filing | Purushothaman Balaji Officer (Chief Human Resources Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $145.12 exercise price | 2023-01-04 | ||
| 2023-01-04 holding as of filing | Purushothaman Balaji Officer (Chief Human Resources Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $128.51 exercise price | 2023-01-04 | ||
| 2023-01-04 holding as of filing | Purushothaman Balaji Officer (Chief Human Resources Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $137.44 exercise price | 2023-01-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| Longevity Health Holdings, Inc. (XAGE) | United States | $0.006B | -0.09 |